Purpose: Despite success rates favoring ureteroneocystostomy over subureteral injection of dextranomer/hyaluronic acid for correction of vesicoureteral reflux, the reported incidence of postoperative febrile urinary tract infection favors the latter. We evaluated contemporary treatment cohorts for an association between correction of vesicoureteral reflux and risk of postoperative febrile urinary tract infection.
Materials And Methods: We retrospectively reviewed the records of 396 consecutive patients who underwent ureteroneocystostomy or subureteral injection of dextranomer/hyaluronic acid between 1994 and 2008. Time to event multivariate analyses included preoperative grade of vesicoureteral reflux and bladder/bowel dysfunction.
Results: Of 316 patients meeting study criteria 210 underwent ureteroneocystostomy (356 ureters) and 106 underwent subureteral injection of dextranomer/hyaluronic acid (167). Median patient age was 5.7 years (IQR 3.4 to 8.3). Median followup was 28 months (IQR 8 to 61). Ureteral success was significantly greater after ureteroneocystostomy (88%, 314 of 356 cases) vs subureteral injection of dextranomer/hyaluronic acid (74%, 124 of 167, p = 0.0001). When controlling for preoperative grade of vesicoureteral reflux and bladder/bowel dysfunction, the risk of persistent reflux was 2.8 times greater after subureteral injection of dextranomer/hyaluronic acid (95% CI 1.7-4.7, p <0.0001). The incidence of febrile urinary tract infection did not significantly differ between ureteroneocystostomy (8%, 16 of 210 cases) and subureteral injection of dextranomer/hyaluronic acid (4%, 4 of 106; HR 1.96, 95% CI 0.64-5.9, p = 0.24) even when controlling for preoperative grade of vesicoureteral reflux, a predictor of postoperative febrile urinary tract infection on multivariate analysis (HR 2.2 per increase in grade, 95% CI 1.3-3.6, p = 0.0022). Persistent reflux was not a predictor of postoperative febrile urinary tract infection (HR 0.81, 95% CI 0.22-2.9, p = 0.75 for ureteroneocystostomy vs HR 1.8, 95% CI 0.2-17.3, p = 0.6 for subureteral injection of dextranomer/hyaluronic acid and HR 1.8, 95% CI 0.3-3.3, p = 0.6 for both).
Conclusions: The incidence of postoperative febrile urinary tract infection may be independent of radiographic procedural success.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.juro.2012.09.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Factors Influencing Success in Endoscopic Treatment of Grade 4-5 Primary Vesicoureteric Reflux (VUR) in Infancy and Childhood.
J Pediatr Surg
January 2025
Chelsea & Westminster Hospital and Imperial College Hospitals (West London Children's Hospital Alliance), Imperial College London, United Kingdom. Electronic address:
Introduction: There is equipoise among pediatric urologists regarding endoscopic versus surgical intervention for symptomatic Grade 4-5 Vesicoureteric Reflux (VUR), particularly in infancy. Our aim was to assess outcomes of first-line endoscopic treatment in all cases of symptomatic Grade 4-5 VUR and we hypothesised that using endoscopic Dx/HA as first line management for primary VUR would obviate the need for ureteric reimplantation in the majority of cases.
Methods: Retrospective single-surgeon analysis of consecutive patients with primary Grade 4-5 VUR over 15 years.
Transitional Outcomes of Adults Who Underwent Cohen Ureteroneocystostomy for the Treatment of Vesicoureteral Reflux as Children.
Urology
December 2024
İstanbul University, İstanbul Faculty of Medicine, Turkey.
Article Synopsis
- The study aimed to assess the outcomes of children who underwent Cohen ureteroneocystostomy (UNC) for vesicoureteral reflux (VUR) over a long-term follow-up period.
- A retrospective review of 241 patients revealed that 28.6% experienced lower urinary tract dysfunction (LUTD) in adulthood, with various factors such as being female and having a history of bladder-bowel dysfunction influencing this outcome.
- Despite effective management of VUR, a small percentage of patients still faced complications like febrile urinary tract infections (UTIs) and hypertension, highlighting the need for ongoing monitoring and care even after surgical intervention.
Subureteric injection for the treatment of vesicoureteral reflux in transplant kidneys.
Can Urol Assoc J
November 2024
Department of Urology, Faculty of Medicine, Istanbul University Istanbul, Istanbul, Turkey.
Introduction: Treatment of de novo vesicoureteral reflux (VUR) into the transplanted kidney constitutes a clinical challenge. Herein, we present our data on patients who underwent endoscopic subureteric injection for the treatment of VUR following renal transplantation (RT) in our center.
Methods: The patients who underwent endoscopic subureteric injection for VUR into the transplanted kidney after RT in our department between 2008 and 2023 were reviewed retrospectively.
Primary vesicoureteral reflux.
Nat Rev Dis Primers
October 2024
Departments of Paediatrics (Nephrology) and Urology, Wayne State University School of Medicine, Detroit, MI, USA.
Article Synopsis
- Primary vesicoureteral reflux (VUR) is a common condition in children where urine flows backward from the bladder, leading to urinary tract infections and potential kidney damage.
- The primary goals for treating VUR in kids are to prevent UTIs and reduce the risk of kidney problems, with available management options including antibiotics, surveillance, and various surgical techniques.
- Ongoing debates focus on the timing of imaging tests and identifying which patients will benefit most from either antibiotics or surgical treatments, with new technologies like artificial intelligence offering future support in decision-making.
Asymmetrical primary vesicoureteral reflux: Which is the best surgical strategy?
J Pediatr Urol
December 2024
Department of Pediatric Surgery and Urology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Cité, Paris, France.
Article Synopsis
- A study was conducted to evaluate the effectiveness of a combined surgical technique for treating primary asymmetrical vesicoureteral reflux in children, comparing it to the standard method of bilateral cross-trigonal reimplantation.
- The research focused on surgical complications, post-operative urinary tract infections (fUTIs), and the need for further interventions over an 18-year period, involving 80 children who had experienced febrile UTIs.
- Results showed comparable success rates between the two surgical groups, but the combined technique had a significantly shorter hospital stay and reduced need for bladder catheters and ureteral stents.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!